List of Cequa drug patents

Cequa is owned by Sun Pharm.

Cequa contains Cyclosporine.

Cequa has a total of 4 drug patents out of which 0 drug patents have expired.

Cequa was authorised for market use on 14 August, 2018.

Cequa is available in solution;ophthalmic dosage forms.

Cequa can be used as increase tear production in patients with keratoconjunctivitis sicca (dry eye)..

The generics of Cequa are possible to be released after 28 February, 2037.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8980839 SUN PHARM Topical aqueous nanomicellar, ophthalmic solutions and uses thereof
Aug, 2033

(10 years from now)

US9937225 SUN PHARM Topical formulations and uses thereof
Aug, 2033

(10 years from now)

US10441630 SUN PHARM Topical formulations and uses thereof
Aug, 2033

(10 years from now)

US10918694 SUN PHARM Topical cyclosporine-containing formulations and uses thereof
Feb, 2037

(14 years from now)

Drugs and Companies using CYCLOSPORINE ingredient

Market Authorisation Date: 14 August, 2018

Treatment: Increase tear production in patients with keratoconjunctivitis sicca (dry eye).

Dosage: SOLUTION;OPHTHALMIC

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in